CCP
ABBV icon

Carmel Capital Partners’s AbbVie ABBV Stock Holding History

Carmel Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Buy
1,210
+68
+6% +$15.1K 0.1% 101
2025
Q4 		$261K Sell
1,142
-807
-41% -$184K 0.09% 98
2025
Q3 		$451K Sell
1,949
-1,633
-46% -$333K 0.19% 77
2025
Q2 		$665K Sell
3,582
-145
-4% -$26.9K 0.23% 78
2025
Q1 		$781K Sell
3,727
-19
-0.5% -$3.69K 0.31% 67
2024
Q4 		$666K Sell
3,746
-306
-8% -$56.3K 0.27% 69
2024
Q3 		$800K Sell
4,052
-54
-1% -$10.1K 0.31% 66
2024
Q2 		$704K Buy
4,106
+45
+1% +$7.45K 0.3% 66
2024
Q1 		$740K Hold
4,061
– – 0.31% 67
2023
Q4 		$629K Sell
4,061
-589
-13% -$85.9K 0.32% 66
2023
Q3 		$693K Buy
4,650
+491
+12% +$72.1K 0.31% 68
2023
Q2 		$560K Buy
4,159
+22
+0.5% +$3.23K 0.29% 66
2023
Q1 		$659K Sell
4,137
-451
-10% -$69K 0.39% 60
2022
Q4 		$741K Buy
4,588
+775
+20% +$119K 0.51% 48
2022
Q3 		$512K Buy
3,813
+117
+3% +$16.8K 0.49% 56
2022
Q2 		$566K Buy
3,696
+342
+10% +$52.3K 0.53% 59
2022
Q1 		$544K Buy
3,354
+302
+10% +$43.9K 0.45% 60
2021
Q4 		$413K Buy
+3,052
New +$361K 0.31% 67

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carmel Capital Partners's ABBV Position: Q1 2026 in Review

Carmel Capital Partners increased its AbbVie (ABBV) stake by 6% in Q1 2026, buying an estimated $15.1K and bringing the position to 1,210 shares worth $263K. The position accounts for 0.1% of the portfolio, ranked #101.

Carmel Capital Partners first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $800K in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Carmel Capital Partners held 1,210 shares of AbbVie worth $263K as of Q1 2026.
  • Carmel Capital Partners bought 68 AbbVie shares in Q1 2026, an estimated $15.1K.
  • AbbVie made up 0.1% of Carmel Capital Partners's portfolio in Q1 2026, its #101 holding.
  • Carmel Capital Partners first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Carmel Capital Partners's AbbVie position peaked at $800K in Q3 2024.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Carmel Capital Partners's 13F filing for Q1 2026, filed 30 Apr 2026.